CN104447286A - Soluble selenium/calcium citrate and preparation method thereof - Google Patents
Soluble selenium/calcium citrate and preparation method thereof Download PDFInfo
- Publication number
- CN104447286A CN104447286A CN201410625899.6A CN201410625899A CN104447286A CN 104447286 A CN104447286 A CN 104447286A CN 201410625899 A CN201410625899 A CN 201410625899A CN 104447286 A CN104447286 A CN 104447286A
- Authority
- CN
- China
- Prior art keywords
- selenium
- citrate
- preparation
- lime
- calcium citrate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000011669 selenium Substances 0.000 title claims abstract description 41
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 title claims abstract description 39
- 229910052711 selenium Inorganic materials 0.000 title claims abstract description 39
- 238000002360 preparation method Methods 0.000 title claims abstract description 17
- 239000001354 calcium citrate Substances 0.000 title abstract 7
- FNAQSUUGMSOBHW-UHFFFAOYSA-H calcium citrate Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O FNAQSUUGMSOBHW-UHFFFAOYSA-H 0.000 title abstract 7
- 235000013337 tricalcium citrate Nutrition 0.000 title abstract 7
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims abstract description 44
- 238000006243 chemical reaction Methods 0.000 claims abstract description 15
- BRPQOXSCLDDYGP-UHFFFAOYSA-N calcium oxide Chemical compound [O-2].[Ca+2] BRPQOXSCLDDYGP-UHFFFAOYSA-N 0.000 claims abstract description 9
- 239000000292 calcium oxide Substances 0.000 claims abstract description 9
- ODINCKMPIJJUCX-UHFFFAOYSA-N calcium oxide Inorganic materials [Ca]=O ODINCKMPIJJUCX-UHFFFAOYSA-N 0.000 claims abstract description 9
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 claims description 24
- 235000008733 Citrus aurantifolia Nutrition 0.000 claims description 24
- 235000011941 Tilia x europaea Nutrition 0.000 claims description 24
- 239000004571 lime Substances 0.000 claims description 24
- -1 tin anhydride Chemical class 0.000 claims description 8
- 239000000843 powder Substances 0.000 claims description 6
- 239000011135 tin Substances 0.000 claims description 6
- 238000004806 packaging method and process Methods 0.000 claims description 3
- 238000003746 solid phase reaction Methods 0.000 claims description 3
- 238000010671 solid-state reaction Methods 0.000 claims description 3
- 238000012856 packing Methods 0.000 claims description 2
- 230000035484 reaction time Effects 0.000 claims description 2
- 239000011575 calcium Substances 0.000 abstract description 12
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 abstract description 9
- 229910052791 calcium Inorganic materials 0.000 abstract description 9
- 235000013305 food Nutrition 0.000 abstract description 5
- 230000036541 health Effects 0.000 abstract description 5
- 206010061218 Inflammation Diseases 0.000 abstract description 4
- 239000000126 substance Substances 0.000 abstract description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 4
- 239000000463 material Substances 0.000 abstract description 3
- JPJALAQPGMAKDF-UHFFFAOYSA-N selenium dioxide Chemical compound O=[Se]=O JPJALAQPGMAKDF-UHFFFAOYSA-N 0.000 abstract 4
- 229960004106 citric acid Drugs 0.000 abstract 2
- 241000894006 Bacteria Species 0.000 abstract 1
- 208000034630 Calculi Diseases 0.000 abstract 1
- 229960004543 anhydrous citric acid Drugs 0.000 abstract 1
- 230000003467 diminishing effect Effects 0.000 abstract 1
- 230000036449 good health Effects 0.000 abstract 1
- 230000004054 inflammatory process Effects 0.000 abstract 1
- 239000007790 solid phase Substances 0.000 abstract 1
- 230000001502 supplementing effect Effects 0.000 abstract 1
- 208000008281 urolithiasis Diseases 0.000 abstract 1
- 239000000047 product Substances 0.000 description 11
- 230000000694 effects Effects 0.000 description 5
- 210000000988 bone and bone Anatomy 0.000 description 4
- 230000003203 everyday effect Effects 0.000 description 4
- 230000003260 anti-sepsis Effects 0.000 description 3
- 239000013078 crystal Substances 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- 210000005036 nerve Anatomy 0.000 description 3
- 208000024172 Cardiovascular disease Diseases 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 208000019926 Keshan disease Diseases 0.000 description 2
- 208000009525 Myocarditis Diseases 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000036592 analgesia Effects 0.000 description 2
- 230000002052 anaphylactic effect Effects 0.000 description 2
- 230000003712 anti-aging effect Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 208000029078 coronary artery disease Diseases 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000036737 immune function Effects 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 238000012423 maintenance Methods 0.000 description 2
- 230000004899 motility Effects 0.000 description 2
- 201000008482 osteoarthritis Diseases 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 1
- ROFDGMHLHSBFKJ-QTNFYWBSSA-N N[C@@H](CCC(O)=O)C(O)=O.N.[SeH2] Chemical compound N[C@@H](CCC(O)=O)C(O)=O.N.[SeH2] ROFDGMHLHSBFKJ-QTNFYWBSSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 238000009098 adjuvant therapy Methods 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 230000000536 complexating effect Effects 0.000 description 1
- 239000008139 complexing agent Substances 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 230000006651 lactation Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000004118 muscle contraction Effects 0.000 description 1
- 235000020939 nutritional additive Nutrition 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000005062 synaptic transmission Effects 0.000 description 1
- 238000010189 synthetic method Methods 0.000 description 1
- 231100000816 toxic dose Toxicity 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
- C07C51/41—Preparation of salts of carboxylic acids
- C07C51/412—Preparation of salts of carboxylic acids by conversion of the acids, their salts, esters or anhydrides with the same carboxylic acid part
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/235—Saturated compounds containing more than one carboxyl group
- C07C59/245—Saturated compounds containing more than one carboxyl group containing hydroxy or O-metal groups
- C07C59/265—Citric acid
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Life Sciences & Earth Sciences (AREA)
- Mycology (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention relates to a new substance (selenium/calcium citrate) and a preparation method thereof. The preparation method of the selenium/calcium citrate comprises the following steps: (1) adding anhydrous citric acid, calcium oxide and selenium dioxide into a reaction vessel, grinding and carrying out solid-phase chemical reaction; and (2) obtaining the product soluble selenium/calcium citrate after the materials react sufficiently. The selenium/calcium citrate provided by the invention is prepared from citric acid, calcium oxide and selenium dioxide, is capable of supplementing such two inorganic elements as calcium and selenium simultaneously, is soluble in water and can be absorbed by a human body. Citric acid in the selenium/calcium citrate has the functions of resisting bacteria, diminishing inflammation and dissolving calculuses. The selenium/calcium citrate is a good health product and can be widely applied to various foods and health products.
Description
Technical field
The present invention relates to biochemical industry medicine food field, especially relate to a kind of novel substance citrate of lime selenium and preparation method thereof.
Background technology
Calcium is biological required element.For human body, no matter in muscle, nerve, body fluid and bone, all useful Ca
2+in conjunction with protein.Calcium is the main inorganic composition of mankind's bone, tooth, is also the necessary elements such as neurotransmission, Muscle contraction, coagulation of blood, hormone release and lactation.Calcium accounts for 1.4% of body mass, and participate in metabolism, every day must supplement calcium; In human body, calcium contents deficiency or surplus all can affect and grow and health, positively charged ion calcium Ca
2+there is strong bone, healthy tooth, anti-inflammatory, analgesia, maintenance nerve and the NE of muscle, have effect for the treatment of anaphylactic disease.
Selenium Se is the nutritional additive of people, animal, and organoselenium human body easily absorbs.There is anti-ageing, to improve motility of sperm and toxin expelling effect.Can cardiovascular diseases be prevented, maintain heart normal operation; Anti-oxidant, improve immunologic function; Anti-curing cancers, hypertension, coronary heart disease, myocarditis, Keshan disease, Kaschin-Beck disease etc.Therefore World Health Organization's suggestion supplements 200 microgram selenium every day, can effective prevention of various diseases occurred frequently.United States Medicine academy of sciences is thought, the minimum toxic dose of selenium is microgram every day 900, if it is safe that the content of the selenium taken in from diet and selenium product every day is no more than 400 micrograms.
Citric acid C
6h
8o
7be flavour of food products acid complexing agent, can antisepsis and anti-inflammation be used as, because citric acid the caoxalate of complexing courage kidney vesicoureteral calculus can become easy molten citrate of lime, calculus can also be made to diminish and disappear.
On the outer market of Now Domestic, easy molten citrate of lime selenium does not also occur
Summary of the invention
The object of the invention is to the blank filling up prior art, a kind of synthetic method of easy molten citrate of lime selenium is provided.
The present invention is achieved by the following technical solutions:
A preparation method for easy molten citrate of lime selenium, comprises the following steps:
(1) Citric Acid, usp, Anhydrous Powder, calcium oxide and tin anhydride are dropped into reaction vessel, grind rear generation solid state reaction;
(2), after fully reacting, the easy molten citrate of lime selenium of product is obtained.
Further, described step (1) drops into the mol ratio of Citric Acid, usp, Anhydrous Powder, calcium oxide and tin anhydride is 2202:3301:1.
Further, the reaction vessel of described step (1) is agitating ball mill.
Further, the chemical reaction of described step (1) carries out at normal temperatures.
Further, the reaction times of the chemical reaction of described step (1) is 30 minutes.
Further, the preparation method of described easy molten citrate of lime selenium also comprises step (3): the product packing terminated reaction, and packaging obtains finished product.
Another object of the present invention is to provide a kind of new material citrate of lime selenium, and it obtains according to above-mentioned arbitrary described preparation method.
Compared with prior art, the present invention has the following advantages:
The citrate of lime selenium that the present invention prepares, has another name called Tricalcium dicitrate selenium, chemical structure molecular formula SeCa
3301(C
6h
5o
7)
22023303H
2o, white crystalline powder, molecular weight 608323.3, containing selenium 0.01%, calcic 21.75%, containing citric acid 68.46%, containing crystal water 9.78%, purity more than 99%, water-soluble (0.82g Ca/100ml, 25 DEG C, 0.0004g Se/100ml, 25 DEG C).
Citrate of lime selenium of the present invention is prepared from by citric acid, calcium oxide and tin anhydride.Calcium and selenium two kinds of inorganic elementss can be supplemented simultaneously, soluble in water, can by body absorption.Strong bone, healthy tooth, anti-inflammatory, analgesia, maintenance nerve and the NE of muscle can be played, play the adjuvant treatment efficacy of anaphylactic disease; In addition, also there is anti-ageing, to improve motility of sperm and toxin expelling effect, can cardiovascular diseases be prevented, maintain heart normal operation, anti-oxidant, improve immunologic function, anti-curing cancers, hypertension, coronary heart disease, myocarditis, Keshan disease, Kaschin-Beck disease etc.; Its citric acid composition plays antisepsis and anti-inflammation in vivo and clears up the effect of calculus, is a kind of well health care's product, in various food and healthcare products, can be able to be widely used.
Embodiment
Below the preferred embodiments of the present invention are described.The purpose of these embodiments is illustrative, and should not be construed as limitation of the present invention.
The present embodiment is the preparation method of citrate of lime selenium, comprises the following steps:
(1) tin anhydride 110.96g, calcium oxide 185120.1g and Citric Acid, usp, Anhydrous Powder 423092.3 is taken, mixed by above-mentioned materials, drop into agitating ball mill and carry out solid state reaction, half an hour is reacted in start, reaction generates monoammonium glutamate selenium, and chemical equation is:
SeO
2+3301CaO+2202C
6H
8O
7＝SeCa
3301(C
6H
5O
7)
2202·3303H
2O，
Reaction conditions is normal temperature;
(2) fully reaction, after 30 minutes, releases product from agitating ball mill;
(3), after the finished product of acquisition fully being reacted, obtain product citrate of lime selenium crystals weighed, obtain easy molten citrate of lime selenium crystal 608323.3g, then packaging final prod.
Citrate of lime selenium of the present invention is prepared from by citric acid, calcium oxide and tin anhydride.Calcium and selenium two kinds of inorganic elementss can be supplemented simultaneously, soluble in water, can by body absorption, its citric acid composition plays antisepsis and anti-inflammation in vivo and clears up the effect of calculus, be a kind of well health care's product, in various food and healthcare products, can be able to be widely used.
These are only the preferred embodiments of the present invention; be not limited to the present invention; for a person skilled in the art, all any amendments done within the spirit and principles in the present invention, equivalent replacement, improvement etc., all should be included within protection scope of the present invention.
Claims (7)
1. a preparation method for easy molten citrate of lime selenium, comprises the following steps:
(1) Citric Acid, usp, Anhydrous Powder, calcium oxide and tin anhydride are dropped into reaction vessel, grind rear generation solid state reaction;
(2), after fully reacting, the easy molten citrate of lime selenium of product is obtained.
2. the preparation method of easy molten citrate of lime selenium according to claim 1, is characterized in that: described step (1) drop into Citric Acid, usp, Anhydrous Powder, calcium oxide and tin anhydride mole ratio be 2202:3301:1.
3. the preparation method of easy molten citrate of lime selenium according to claim 1, is characterized in that: the reaction vessel of described step (1) is agitating ball mill.
4. the preparation method of easy molten citrate of lime selenium according to claim 1, is characterized in that: the chemical reaction of described step (1) carries out at normal temperatures.
5. the preparation method of easy molten citrate of lime selenium according to claim 1, is characterized in that: the reaction times of the chemical reaction of described step (1) is 30 minutes.
6. the preparation method of easy molten citrate of lime selenium according to claim 1, is characterized in that: the preparation method of described molten citrate of lime selenium also comprises step (3): the product packing terminated reaction, and packaging obtains finished product.
7. easy the to be molten citrate of lime selenium prepared according to the arbitrary described preparation method of claim 1 ~ 6.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410625899.6A CN104447286A (en) | 2014-11-07 | 2014-11-07 | Soluble selenium/calcium citrate and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410625899.6A CN104447286A (en) | 2014-11-07 | 2014-11-07 | Soluble selenium/calcium citrate and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104447286A true CN104447286A (en) | 2015-03-25 |
Family
ID=52894124
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410625899.6A Pending CN104447286A (en) | 2014-11-07 | 2014-11-07 | Soluble selenium/calcium citrate and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104447286A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106699782A (en) * | 2016-12-28 | 2017-05-24 | 李玉成 | Citric acid-ascorbic acid hydrogen calcium zinc and preparation method and application thereof |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101050134A (en) * | 2007-05-18 | 2007-10-10 | 吴礼树 | Fertilizer of chelated calcium, and preparation method |
| US7351853B2 (en) * | 2006-01-23 | 2008-04-01 | Albion Advanced Nutrition | Method of manufacturing a granular mineral composition |
| US20100080856A1 (en) * | 2008-09-26 | 2010-04-01 | Costantino Peter D | Method and composition for postoperative wound healing |
| CN101823954A (en) * | 2010-06-03 | 2010-09-08 | 西陇化工股份有限公司 | Method for preparing disodium stannous citrate |
-
2014
- 2014-11-07 CN CN201410625899.6A patent/CN104447286A/en active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7351853B2 (en) * | 2006-01-23 | 2008-04-01 | Albion Advanced Nutrition | Method of manufacturing a granular mineral composition |
| CN101050134A (en) * | 2007-05-18 | 2007-10-10 | 吴礼树 | Fertilizer of chelated calcium, and preparation method |
| US20100080856A1 (en) * | 2008-09-26 | 2010-04-01 | Costantino Peter D | Method and composition for postoperative wound healing |
| CN101823954A (en) * | 2010-06-03 | 2010-09-08 | 西陇化工股份有限公司 | Method for preparing disodium stannous citrate |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106699782A (en) * | 2016-12-28 | 2017-05-24 | 李玉成 | Citric acid-ascorbic acid hydrogen calcium zinc and preparation method and application thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1680258A (en) | Amorphous water-soluble calcium citrate salts and method of making and using same | |
| JP2009062370A (en) | Solid composition for reducing tooth erosion | |
| CN103739579A (en) | Citric acid dehydrogenated calcium ascorbate and preparation method and application thereof | |
| KR101262293B1 (en) | Method of Manufacturing Stable and High Concentration Calcium Phosphate Aqueous Solutions in Neutral pH Range | |
| CN103690559A (en) | Formulation form of supplement calcium, magnesium, iron, zinc and iodine, and oral liquid preparation method of formulation | |
| CN101747179B (en) | Method for preparing citric acid malic acid calcium | |
| CN103815227A (en) | Composite vitamin brown sugar composition and application thereof | |
| CN103535721B (en) | Improve composition and method of making the same and the application of glutathione concentration in human body | |
| CN104356101A (en) | Calcium acetylsalicylate ascorbate and preparation method thereof | |
| CA3131085C (en) | Silicon ion complex organized with carboxylic acid, preparation method for silicon ion complex, and product using the same | |
| RU2018110274A (en) | COMPOSITION OF MINERAL SUBSTANCES TO STIMULATE CARBOHYDRATE METABOLISM | |
| CN103169092A (en) | L-asparaginic acid chelated calcium drinking water | |
| CN104447286A (en) | Soluble selenium/calcium citrate and preparation method thereof | |
| JP2004175701A (en) | Mineral absorption promoter | |
| RU2454085C2 (en) | Fruit-and-jelly milk desert | |
| CN102018207A (en) | Walnut powder and processing technology thereof | |
| JP7253178B2 (en) | Composition containing hydrogen generating material and method for producing the same | |
| JP2009539381A (en) | Calcium fortifying substances for clear beverages | |
| CN1303904C (en) | Olive calcium tablet | |
| CN109527590A (en) | A kind of basic protein protein powder of novel strong bone and preparation method thereof | |
| JP7378121B2 (en) | Method for producing silica-containing products | |
| CN106699782A (en) | Citric acid-ascorbic acid hydrogen calcium zinc and preparation method and application thereof | |
| WO2023104306A1 (en) | Gel-like food supplement composition | |
| JPH03168067A (en) | Production of magnesium solution containing magnesium and magnesium compound at high concentration and medicine and processed food using the same magnesium solution | |
| CN102038194A (en) | Calcium protein powder of marine organisms |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20150325 |
|
| RJ01 | Rejection of invention patent application after publication |